menu
    • menu

    Company profile for Phrontline Biopharma

    NEW Drugs in Dev.: 3
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Phrontline Biopharma is an innovative biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) to address critical unmet needs in oncology. Leveraging expertise in dual-targeting antibody engineering, we enhance the precision and potency of targeted payload delivery. Our proprietary dual-payload platform is designed to overcome drug resistance and extend treatment durability, inspired by the ...
    Phrontline Biopharma is an innovative biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) to address critical unmet needs in oncology. Leveraging expertise in dual-targeting antibody engineering, we enhance the precision and potency of targeted payload delivery. Our proprietary dual-payload platform is designed to overcome drug resistance and extend treatment durability, inspired by the proven benefits of combination chemotherapy. Guided by science and driven by innovation, Phrontline aims to become a global leader in advancing breakthrough cancer therapies for patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Phrontline BiopharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Suite 502, Building B, No. 1976 Middle Gaoke Road, Pudong New Area, Shanghai
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.phrontlinebio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phrontline Pharma Raises $60M for Bispecific, Dual ADCs
    Phrontline Pharma Raises $60M for Bispecific, Dual ADCs

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phrontline-biopharma-raises-60-million-in-pre-a-financing-to-advance-global-development-of-bispecific-and-dual-payload-adcs-302625090.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share
    Samsung Bioepis Phrontline Partner For ADCs In Solid Tumors
    Samsung Bioepis Phrontline Partner For ADCs In Solid Tumors

    20 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020320860/en/Samsung-Bioepis-And-Phrontline-Announce-a-Global-Strategic-Partnership-to-Advance-Best-in-Class-Antibody-Drug-Conjugate-Therapeutics-for-Solid-Tumors

    BUSINESSWIRE
    20 Oct 2025
    Share Share
    Phrontline Biopharma Initiates Phase 1 Trial for TJ101
    Phrontline Biopharma Initiates Phase 1 Trial for TJ101

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phrontline-biopharma-announces-first-patient-dosed-in-phase-1-clinical-trial-of-tj101-302555704.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search